Optimal gestational weight gain in women with pregestational type 2 diabetes: a population-based cohort study in China
The global prevalence of pregestational type 2 diabetes mellitus (T2DM) has increased concurrently with increasing rates of overweight and obesity. Effective weight management during pregnancy is critically associated with maternal and neonatal outcomes. However, no universally accepted guidelines f...
Saved in:
Published in | Diabetology and metabolic syndrome Vol. 17; no. 1; pp. 339 - 11 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
18.08.2025
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The global prevalence of pregestational type 2 diabetes mellitus (T2DM) has increased concurrently with increasing rates of overweight and obesity. Effective weight management during pregnancy is critically associated with maternal and neonatal outcomes. However, no universally accepted guidelines for gestational weight gain (GWG) in high-risk pregnancies with T2DM currently exist.
A nationwide, multicenter cohort of 2078 T2DM pregnancies was analyzed, categorizing GWG based on latest Chinese guidelines. Multivariate regression analyses were performed to evaluate the impact of GWG deviations on adverse pregnancy outcomes. Interquartile range (IQR) analysis and restricted cubic splines were used to determine BMI-specific GWG targets.
The results showed that insufficient GWG was protective against cesarean delivery, large-for-gestational-age (LGA), and macrosomia but increased risks of preterm birth and congenital anomalies. Excessive GWG significantly elevated risks of preeclampsia, LGA, macrosomia, and neonatal hypoglycemia, while protecting against small-for-gestational-age (SGA). Using interquartile range method, we identified GWG ranges for normal-weight, overweight, and obese women were 7.0-12.5 kg, 5.0-11.0 kg, and 4.0-11.2 kg, respectively. Restricted cubic splines suggested relaxing the lower limit to 6 kg for normal BMI but showed risks below 1.8 kg. For overweight and obese women, GWG below guideline limits was beneficial.
The current GWG guidelines may not fully suit T2DM pregnancies, particularly for overweight and obese women, highlighting the need for BMI-specific recommendations to optimize maternal and neonatal outcomes. |
---|---|
AbstractList | Abstract Background The global prevalence of pregestational type 2 diabetes mellitus (T2DM) has increased concurrently with increasing rates of overweight and obesity. Effective weight management during pregnancy is critically associated with maternal and neonatal outcomes. However, no universally accepted guidelines for gestational weight gain (GWG) in high-risk pregnancies with T2DM currently exist. Methods A nationwide, multicenter cohort of 2078 T2DM pregnancies was analyzed, categorizing GWG based on latest Chinese guidelines. Multivariate regression analyses were performed to evaluate the impact of GWG deviations on adverse pregnancy outcomes. Interquartile range (IQR) analysis and restricted cubic splines were used to determine BMI-specific GWG targets. Results The results showed that insufficient GWG was protective against cesarean delivery, large-for-gestational-age (LGA), and macrosomia but increased risks of preterm birth and congenital anomalies. Excessive GWG significantly elevated risks of preeclampsia, LGA, macrosomia, and neonatal hypoglycemia, while protecting against small-for-gestational-age (SGA). Using interquartile range method, we identified GWG ranges for normal-weight, overweight, and obese women were 7.0–12.5 kg, 5.0–11.0 kg, and 4.0–11.2 kg, respectively. Restricted cubic splines suggested relaxing the lower limit to 6 kg for normal BMI but showed risks below 1.8 kg. For overweight and obese women, GWG below guideline limits was beneficial. Conclusion The current GWG guidelines may not fully suit T2DM pregnancies, particularly for overweight and obese women, highlighting the need for BMI-specific recommendations to optimize maternal and neonatal outcomes. The global prevalence of pregestational type 2 diabetes mellitus (T2DM) has increased concurrently with increasing rates of overweight and obesity. Effective weight management during pregnancy is critically associated with maternal and neonatal outcomes. However, no universally accepted guidelines for gestational weight gain (GWG) in high-risk pregnancies with T2DM currently exist. A nationwide, multicenter cohort of 2078 T2DM pregnancies was analyzed, categorizing GWG based on latest Chinese guidelines. Multivariate regression analyses were performed to evaluate the impact of GWG deviations on adverse pregnancy outcomes. Interquartile range (IQR) analysis and restricted cubic splines were used to determine BMI-specific GWG targets. The results showed that insufficient GWG was protective against cesarean delivery, large-for-gestational-age (LGA), and macrosomia but increased risks of preterm birth and congenital anomalies. Excessive GWG significantly elevated risks of preeclampsia, LGA, macrosomia, and neonatal hypoglycemia, while protecting against small-for-gestational-age (SGA). Using interquartile range method, we identified GWG ranges for normal-weight, overweight, and obese women were 7.0-12.5 kg, 5.0-11.0 kg, and 4.0-11.2 kg, respectively. Restricted cubic splines suggested relaxing the lower limit to 6 kg for normal BMI but showed risks below 1.8 kg. For overweight and obese women, GWG below guideline limits was beneficial. The current GWG guidelines may not fully suit T2DM pregnancies, particularly for overweight and obese women, highlighting the need for BMI-specific recommendations to optimize maternal and neonatal outcomes. The global prevalence of pregestational type 2 diabetes mellitus (T2DM) has increased concurrently with increasing rates of overweight and obesity. Effective weight management during pregnancy is critically associated with maternal and neonatal outcomes. However, no universally accepted guidelines for gestational weight gain (GWG) in high-risk pregnancies with T2DM currently exist.BACKGROUNDThe global prevalence of pregestational type 2 diabetes mellitus (T2DM) has increased concurrently with increasing rates of overweight and obesity. Effective weight management during pregnancy is critically associated with maternal and neonatal outcomes. However, no universally accepted guidelines for gestational weight gain (GWG) in high-risk pregnancies with T2DM currently exist.A nationwide, multicenter cohort of 2078 T2DM pregnancies was analyzed, categorizing GWG based on latest Chinese guidelines. Multivariate regression analyses were performed to evaluate the impact of GWG deviations on adverse pregnancy outcomes. Interquartile range (IQR) analysis and restricted cubic splines were used to determine BMI-specific GWG targets.METHODSA nationwide, multicenter cohort of 2078 T2DM pregnancies was analyzed, categorizing GWG based on latest Chinese guidelines. Multivariate regression analyses were performed to evaluate the impact of GWG deviations on adverse pregnancy outcomes. Interquartile range (IQR) analysis and restricted cubic splines were used to determine BMI-specific GWG targets.The results showed that insufficient GWG was protective against cesarean delivery, large-for-gestational-age (LGA), and macrosomia but increased risks of preterm birth and congenital anomalies. Excessive GWG significantly elevated risks of preeclampsia, LGA, macrosomia, and neonatal hypoglycemia, while protecting against small-for-gestational-age (SGA). Using interquartile range method, we identified GWG ranges for normal-weight, overweight, and obese women were 7.0-12.5 kg, 5.0-11.0 kg, and 4.0-11.2 kg, respectively. Restricted cubic splines suggested relaxing the lower limit to 6 kg for normal BMI but showed risks below 1.8 kg. For overweight and obese women, GWG below guideline limits was beneficial.RESULTSThe results showed that insufficient GWG was protective against cesarean delivery, large-for-gestational-age (LGA), and macrosomia but increased risks of preterm birth and congenital anomalies. Excessive GWG significantly elevated risks of preeclampsia, LGA, macrosomia, and neonatal hypoglycemia, while protecting against small-for-gestational-age (SGA). Using interquartile range method, we identified GWG ranges for normal-weight, overweight, and obese women were 7.0-12.5 kg, 5.0-11.0 kg, and 4.0-11.2 kg, respectively. Restricted cubic splines suggested relaxing the lower limit to 6 kg for normal BMI but showed risks below 1.8 kg. For overweight and obese women, GWG below guideline limits was beneficial.The current GWG guidelines may not fully suit T2DM pregnancies, particularly for overweight and obese women, highlighting the need for BMI-specific recommendations to optimize maternal and neonatal outcomes.CONCLUSIONThe current GWG guidelines may not fully suit T2DM pregnancies, particularly for overweight and obese women, highlighting the need for BMI-specific recommendations to optimize maternal and neonatal outcomes. Background The global prevalence of pregestational type 2 diabetes mellitus (T2DM) has increased concurrently with increasing rates of overweight and obesity. Effective weight management during pregnancy is critically associated with maternal and neonatal outcomes. However, no universally accepted guidelines for gestational weight gain (GWG) in high-risk pregnancies with T2DM currently exist. Methods A nationwide, multicenter cohort of 2078 T2DM pregnancies was analyzed, categorizing GWG based on latest Chinese guidelines. Multivariate regression analyses were performed to evaluate the impact of GWG deviations on adverse pregnancy outcomes. Interquartile range (IQR) analysis and restricted cubic splines were used to determine BMI-specific GWG targets. Results The results showed that insufficient GWG was protective against cesarean delivery, large-for-gestational-age (LGA), and macrosomia but increased risks of preterm birth and congenital anomalies. Excessive GWG significantly elevated risks of preeclampsia, LGA, macrosomia, and neonatal hypoglycemia, while protecting against small-for-gestational-age (SGA). Using interquartile range method, we identified GWG ranges for normal-weight, overweight, and obese women were 7.0-12.5 kg, 5.0-11.0 kg, and 4.0-11.2 kg, respectively. Restricted cubic splines suggested relaxing the lower limit to 6 kg for normal BMI but showed risks below 1.8 kg. For overweight and obese women, GWG below guideline limits was beneficial. Conclusion The current GWG guidelines may not fully suit T2DM pregnancies, particularly for overweight and obese women, highlighting the need for BMI-specific recommendations to optimize maternal and neonatal outcomes. Keywords: Type 2 diabetes mellitus, Gestational weight gain, Adverse pregnancy outcomes The global prevalence of pregestational type 2 diabetes mellitus (T2DM) has increased concurrently with increasing rates of overweight and obesity. Effective weight management during pregnancy is critically associated with maternal and neonatal outcomes. However, no universally accepted guidelines for gestational weight gain (GWG) in high-risk pregnancies with T2DM currently exist. A nationwide, multicenter cohort of 2078 T2DM pregnancies was analyzed, categorizing GWG based on latest Chinese guidelines. Multivariate regression analyses were performed to evaluate the impact of GWG deviations on adverse pregnancy outcomes. Interquartile range (IQR) analysis and restricted cubic splines were used to determine BMI-specific GWG targets. The results showed that insufficient GWG was protective against cesarean delivery, large-for-gestational-age (LGA), and macrosomia but increased risks of preterm birth and congenital anomalies. Excessive GWG significantly elevated risks of preeclampsia, LGA, macrosomia, and neonatal hypoglycemia, while protecting against small-for-gestational-age (SGA). Using interquartile range method, we identified GWG ranges for normal-weight, overweight, and obese women were 7.0-12.5 kg, 5.0-11.0 kg, and 4.0-11.2 kg, respectively. Restricted cubic splines suggested relaxing the lower limit to 6 kg for normal BMI but showed risks below 1.8 kg. For overweight and obese women, GWG below guideline limits was beneficial. The current GWG guidelines may not fully suit T2DM pregnancies, particularly for overweight and obese women, highlighting the need for BMI-specific recommendations to optimize maternal and neonatal outcomes. |
ArticleNumber | 339 |
Audience | Academic |
Author | Wang, Yanxia Kong, Lingyi Zhang, Li Cui, Shihong Gao, Fengchun Chen, Xu Zhu, Ping Xue, Yiwei Yan, Jianying Cui, Zifeng Kang, Xin Yang, Huixia Yao, Mi Shu, Xinyu Juan, Juan Xu, Xia Mi, Yang Chen, Haitian Wei, Zhuo |
Author_xml | – sequence: 1 givenname: Yiwei surname: Xue fullname: Xue, Yiwei – sequence: 2 givenname: Zifeng surname: Cui fullname: Cui, Zifeng – sequence: 3 givenname: Xinyu surname: Shu fullname: Shu, Xinyu – sequence: 4 givenname: Juan surname: Juan fullname: Juan, Juan – sequence: 5 givenname: Xin surname: Kang fullname: Kang, Xin – sequence: 6 givenname: Mi surname: Yao fullname: Yao, Mi – sequence: 7 givenname: Xu surname: Chen fullname: Chen, Xu – sequence: 8 givenname: Zhuo surname: Wei fullname: Wei, Zhuo – sequence: 9 givenname: Lingyi surname: Kong fullname: Kong, Lingyi – sequence: 10 givenname: Haitian surname: Chen fullname: Chen, Haitian – sequence: 11 givenname: Shihong surname: Cui fullname: Cui, Shihong – sequence: 12 givenname: Fengchun surname: Gao fullname: Gao, Fengchun – sequence: 13 givenname: Ping surname: Zhu fullname: Zhu, Ping – sequence: 14 givenname: Jianying surname: Yan fullname: Yan, Jianying – sequence: 15 givenname: Xia surname: Xu fullname: Xu, Xia – sequence: 16 givenname: Li surname: Zhang fullname: Zhang, Li – sequence: 17 givenname: Yanxia surname: Wang fullname: Wang, Yanxia – sequence: 18 givenname: Yang surname: Mi fullname: Mi, Yang – sequence: 19 givenname: Huixia surname: Yang fullname: Yang, Huixia |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40826373$$D View this record in MEDLINE/PubMed |
BookMark | eNptkstq3DAUhk1JaS7tC3RRDIXSjVNdLEvqJoShl0Agm3YtdDm2FTyWa8kZ5u2rmUnDDBQJSRx9-nWO9F8WZ2MYoSjeY3SNsWi-REyRFBUirEKYC1JtXhUXmDNRMSmbs6P1eXEZ4yNCDWe8flOc10iQhnJ6UTw9TMmv9VB2EJNOPox5vQHf9anstB_L3DdhDXn0qS-nGY7BtJ2gJKXz2kCC-LXU5RSmZdjvV0ZHcKUNfZhTGdPitju1Ve9H_bZ43eohwrvn-ar4_f3br9XP6v7hx93q9r6yNWWbSrZSttwa2yLdGmstNcjUjUEEa4yckJzVBlNArrWSNYJLTrllyGIgwtaEXhV3B10X9KOa5lzqvFVBe7UPhLlTek7eDqA4pwIT7ZwBqAETSSy2Lt9NcxLGuKx1c9CaFrMGZ2FMsx5ORE93Rt-rLjwpTCiTomFZ4fOzwhz-LPkd1dpHC8OgRwhLVJTUSGaayox-PKCdzrn5sQ1Z0u5wdSsYoVhQjjJ1_R8qNwdrb7NbWp_jJwc-HR3oQQ-pj2FYdv8VT8EPx8W-VPnPORkgB8DOIcYZ2hcEI7WzpzrYU2V7qr091Yb-BSsS2N0 |
Cites_doi | 10.12114/j.issn.1007-9572.2024.0027 10.2337/dc22-S015 10.1007/s00125-012-2721-z 10.1001/jama.2017.3635 10.1056/NEJM199904223401603 10.1136/bmj.i555 10.1136/bmj-2022-072249 10.1055/s-0036-1585410 10.17226/12584 10.1038/s41440-022-00965-6 10.7326/0003-4819-122-7-199504010-00001 10.1001/jama.2019.3820 10.1093/pch/pxz134 10.1007/s00404-017-4573-8 10.1016/j.diabres.2022.109811 10.1038/nrendo.2016.37 10.31083/j.ceog5102034 10.1111/ppe.12741 10.1080/14767058.2017.1405388 10.1155/2018/1242901 10.1002/bdr2.2165 10.1038/s41430-022-01238-8 10.3389/fendo.2024.1348382 10.2471/blt.07.043497 10.1038/jp.2011.15 10.1186/s12916-018-1128-1 10.1016/j.ajog.2011.06.028 10.1001/jamanetworkopen.2022.33250 10.1186/s12884-022-04762-4 10.1136/bmjopen-2023-075226 10.1111/jog.15448 10.3760/cma.j.cn112141-20210917-00528 10.1111/obr.12521 10.1001/jamanetworkopen.2022.33256 10.1016/j.diabres.2023.110797 10.4236/aasoci.2017.76014 10.1007/s00429-021-02450-1 10.1038/s41572-019-0098-8 10.1016/S0140-6736(24)00255-1 10.1111/1471-0528.17461 10.1111/obr.12238 |
ContentType | Journal Article |
Copyright | 2025. The Author(s). COPYRIGHT 2025 BioMed Central Ltd. The Author(s) 2025 2025 |
Copyright_xml | – notice: 2025. The Author(s). – notice: COPYRIGHT 2025 BioMed Central Ltd. – notice: The Author(s) 2025 2025 |
DBID | AAYXX CITATION NPM 7X8 5PM DOA |
DOI | 10.1186/s13098-025-01782-w |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals (DOAJ) |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1758-5996 |
EndPage | 11 |
ExternalDocumentID | oai_doaj_org_article_773812addbee4e1292c1cdcbc3f99bbd PMC12359865 A852318370 40826373 10_1186_s13098_025_01782_w |
Genre | Journal Article |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GrantInformation_xml | – fundername: the Youth Program of National Natural Science Foundation of China grantid: 82003528 – fundername: National Key Research and Development Program of China grantid: 2021YFC2700700 – fundername: the National High Level Hospital Clinical Research Funding grantid: 22cz020401-4811009 |
GroupedDBID | --- 0R~ 53G 5VS 7X7 8FI 8FJ AAFWJ AAJSJ AASML AAYXX ABDBF ABUWG ACGFO ACGFS ACPRK ACUHS ADBBV ADUKV AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AOIJS BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION DIK E3Z EBD EBLON EBS ESX FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IEA IHR IHW ITC KQ8 M~E O5R O5S OK1 P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC RBZ RNS ROL RPM RSV SMD SOJ TUS U2A UKHRP NPM PUEGO 7X8 5PM |
ID | FETCH-LOGICAL-c435w-9f99f7cbcf0afbccc3b0b46b021a10d89754b13e0dfc956879737c50c1e28c423 |
IEDL.DBID | DOA |
ISSN | 1758-5996 |
IngestDate | Wed Aug 27 01:28:35 EDT 2025 Thu Aug 21 18:23:32 EDT 2025 Wed Aug 20 00:33:50 EDT 2025 Wed Aug 27 16:52:36 EDT 2025 Tue Aug 26 03:41:09 EDT 2025 Tue Aug 26 02:12:35 EDT 2025 Thu Aug 28 04:25:25 EDT 2025 Thu Aug 21 00:29:08 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Gestational weight gain Adverse pregnancy outcomes Type 2 diabetes mellitus |
Language | English |
License | 2025. The Author(s). Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c435w-9f99f7cbcf0afbccc3b0b46b021a10d89754b13e0dfc956879737c50c1e28c423 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://doaj.org/article/773812addbee4e1292c1cdcbc3f99bbd |
PMID | 40826373 |
PQID | 3240912339 |
PQPubID | 23479 |
PageCount | 11 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_773812addbee4e1292c1cdcbc3f99bbd pubmedcentral_primary_oai_pubmedcentral_nih_gov_12359865 proquest_miscellaneous_3240912339 gale_infotracmisc_A852318370 gale_infotracacademiconefile_A852318370 gale_healthsolutions_A852318370 pubmed_primary_40826373 crossref_primary_10_1186_s13098_025_01782_w |
PublicationCentury | 2000 |
PublicationDate | 20250818 |
PublicationDateYYYYMMDD | 2025-08-18 |
PublicationDate_xml | – month: 8 year: 2025 text: 20250818 day: 18 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | Diabetology and metabolic syndrome |
PublicationTitleAlternate | Diabetol Metab Syndr |
PublicationYear | 2025 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | Obstetrics Subgroup, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association, Chinese Society of Perinatal Medicine, Chinese Medical Association, Commitee of Pregnancy with Diabetes Mellitus, China Maternal and Child Health Association (1782_CR22) 2022; 57 J Jia (1782_CR21) 2024; 27 Z Chu (1782_CR38) 2024; 51 AD Gernand (1782_CR40) 2016; 12 X Yan (1782_CR30) 2024; 15 MZ Kapadia (1782_CR44) 2015; 16 MR Narvey (1782_CR27) 2019; 24 DD McIntire (1782_CR43) 1999; 340 1782_CR4 1782_CR11 Z Cheng (1782_CR10) 2023; 77 SV Glinianaia (1782_CR2) 2012; 55 E Voerman (1782_CR15) 2019; 321 1782_CR19 Capital Institute of Pediatrics HL (1782_CR26) 2020; 58 B-F Zhou (1782_CR23) 2002; 15 Y Zhu (1782_CR3) 2024 MS Dos Santos (1782_CR31) 2023; 202 W Kosiek (1782_CR41) 2022; 227 X Fan (1782_CR14) 2023; 49 N Perumal (1782_CR37) 2023; 382 L Toxvig (1782_CR45) 2017; 7 F Chen (1782_CR8) 2022; 5 GA Colditz (1782_CR20) 1995; 122 M de Onis (1782_CR7) 2007; 85 J Fu (1782_CR35) 2022; 186 BA Situ (1782_CR39) 2023; 115 LM Yee (1782_CR12) 2011; 205 X Jiang (1782_CR9) 2019; 32 C Viecceli (1782_CR36) 2017; 18 A Bronisz (1782_CR42) 2018; 2018 1782_CR29 R-X Dai (1782_CR34) 2018; 297 HD McIntyre (1782_CR1) 2019; 5 HJ Teede (1782_CR5) 2022; 5 M Hong (1782_CR18) 2022; 22 B Pethő (1782_CR33) 2023; 130 KR Goetzinger (1782_CR32) 2017; 34 RF Goldstein (1782_CR6) 2018; 16 RF Goldstein (1782_CR16) 2017; 317 H Metoki (1782_CR25) 2022; 45 LM Bodnar (1782_CR28) 2020; 35 JG Ouzounian (1782_CR17) 2011; 31 LC Ismail (1782_CR24) 2016; 352 K Johansson (1782_CR13) 2024; 403 |
References_xml | – volume: 27 start-page: 3609 year: 2024 ident: 1782_CR21 publication-title: Chin General Pract doi: 10.12114/j.issn.1007-9572.2024.0027 – ident: 1782_CR29 doi: 10.2337/dc22-S015 – volume: 55 start-page: 3193 year: 2012 ident: 1782_CR2 publication-title: Diabetologia doi: 10.1007/s00125-012-2721-z – volume: 317 start-page: 2207 year: 2017 ident: 1782_CR16 publication-title: JAMA doi: 10.1001/jama.2017.3635 – volume: 340 start-page: 1234 year: 1999 ident: 1782_CR43 publication-title: N Engl J Med doi: 10.1056/NEJM199904223401603 – volume: 352 year: 2016 ident: 1782_CR24 publication-title: BMJ doi: 10.1136/bmj.i555 – volume: 382 year: 2023 ident: 1782_CR37 publication-title: BMJ doi: 10.1136/bmj-2022-072249 – volume: 34 start-page: 217 year: 2017 ident: 1782_CR32 publication-title: Am J Perinat doi: 10.1055/s-0036-1585410 – ident: 1782_CR4 doi: 10.17226/12584 – volume: 45 start-page: 1298 year: 2022 ident: 1782_CR25 publication-title: Hypertens Res doi: 10.1038/s41440-022-00965-6 – volume: 122 start-page: 481 year: 1995 ident: 1782_CR20 publication-title: Ann Intern Med doi: 10.7326/0003-4819-122-7-199504010-00001 – volume: 321 start-page: 1702 year: 2019 ident: 1782_CR15 publication-title: JAMA doi: 10.1001/jama.2019.3820 – volume: 24 start-page: 536 year: 2019 ident: 1782_CR27 publication-title: Paediatr Child Health doi: 10.1093/pch/pxz134 – volume: 297 start-page: 139 year: 2018 ident: 1782_CR34 publication-title: Arch Gynecol Obstet doi: 10.1007/s00404-017-4573-8 – volume: 186 start-page: 109811 year: 2022 ident: 1782_CR35 publication-title: Diabetes Res Clin Pract doi: 10.1016/j.diabres.2022.109811 – volume: 12 start-page: 274 year: 2016 ident: 1782_CR40 publication-title: Nat Rev Endocrinol doi: 10.1038/nrendo.2016.37 – volume: 51 start-page: 34 year: 2024 ident: 1782_CR38 publication-title: CEOG doi: 10.31083/j.ceog5102034 – volume: 35 start-page: 459 year: 2020 ident: 1782_CR28 publication-title: Paediatr Perinat Epidemiol doi: 10.1111/ppe.12741 – volume: 32 start-page: 1353 year: 2019 ident: 1782_CR9 publication-title: J Matern Fetal Neonatal Med doi: 10.1080/14767058.2017.1405388 – volume: 2018 start-page: 1242901 year: 2018 ident: 1782_CR42 publication-title: Int J Endocrinol doi: 10.1155/2018/1242901 – volume: 115 start-page: 753 year: 2023 ident: 1782_CR39 publication-title: Birth Defects Res doi: 10.1002/bdr2.2165 – volume: 77 start-page: 356 year: 2023 ident: 1782_CR10 publication-title: Eur J Clin Nutr doi: 10.1038/s41430-022-01238-8 – volume: 15 start-page: 1348382 year: 2024 ident: 1782_CR30 publication-title: Front Endocrinol (Lausanne) doi: 10.3389/fendo.2024.1348382 – volume: 85 start-page: 660 year: 2007 ident: 1782_CR7 publication-title: Bull World Health Organ doi: 10.2471/blt.07.043497 – volume: 31 start-page: 717 year: 2011 ident: 1782_CR17 publication-title: J Perinatol doi: 10.1038/jp.2011.15 – volume: 16 start-page: 153 year: 2018 ident: 1782_CR6 publication-title: BMC Med doi: 10.1186/s12916-018-1128-1 – volume: 205 start-page: e1 issue: 257 year: 2011 ident: 1782_CR12 publication-title: Am J Obstet Gynecol doi: 10.1016/j.ajog.2011.06.028 – volume: 5 year: 2022 ident: 1782_CR8 publication-title: JAMA Netw Open doi: 10.1001/jamanetworkopen.2022.33250 – volume: 22 start-page: 424 year: 2022 ident: 1782_CR18 publication-title: Bmc Pregnancy Childb doi: 10.1186/s12884-022-04762-4 – year: 2024 ident: 1782_CR3 publication-title: BMJ Open doi: 10.1136/bmjopen-2023-075226 – volume: 49 start-page: 182 year: 2023 ident: 1782_CR14 publication-title: J Obstet Gynaecol Re doi: 10.1111/jog.15448 – volume: 57 start-page: 3 year: 2022 ident: 1782_CR22 publication-title: Chin J Obstet Gynecol doi: 10.3760/cma.j.cn112141-20210917-00528 – volume: 18 start-page: 567 year: 2017 ident: 1782_CR36 publication-title: Obes Rev doi: 10.1111/obr.12521 – volume: 5 year: 2022 ident: 1782_CR5 publication-title: JAMA Netw Open doi: 10.1001/jamanetworkopen.2022.33256 – volume: 15 start-page: 83 year: 2002 ident: 1782_CR23 publication-title: Biomed Environ Sci – volume: 202 start-page: 110797 year: 2023 ident: 1782_CR31 publication-title: Diabetes Res Clin Pr doi: 10.1016/j.diabres.2023.110797 – volume: 7 start-page: 227 year: 2017 ident: 1782_CR45 publication-title: Adv Appl Sociol doi: 10.4236/aasoci.2017.76014 – ident: 1782_CR11 – volume: 58 start-page: 738 issue: 9 year: 2020 ident: 1782_CR26 publication-title: Chin J Pediatr. – volume: 227 start-page: 1099 year: 2022 ident: 1782_CR41 publication-title: Brain Struct Funct doi: 10.1007/s00429-021-02450-1 – volume: 5 start-page: 47 year: 2019 ident: 1782_CR1 publication-title: Nat Rev Dis Primers doi: 10.1038/s41572-019-0098-8 – volume: 403 start-page: 1472 year: 2024 ident: 1782_CR13 publication-title: The Lancet doi: 10.1016/S0140-6736(24)00255-1 – volume: 130 start-page: 1217 year: 2023 ident: 1782_CR33 publication-title: BJOG doi: 10.1111/1471-0528.17461 – ident: 1782_CR19 – volume: 16 start-page: 189 year: 2015 ident: 1782_CR44 publication-title: Obes Rev doi: 10.1111/obr.12238 |
SSID | ssj0067574 |
Score | 2.3626409 |
Snippet | The global prevalence of pregestational type 2 diabetes mellitus (T2DM) has increased concurrently with increasing rates of overweight and obesity. Effective... Background The global prevalence of pregestational type 2 diabetes mellitus (T2DM) has increased concurrently with increasing rates of overweight and obesity.... Abstract Background The global prevalence of pregestational type 2 diabetes mellitus (T2DM) has increased concurrently with increasing rates of overweight and... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 339 |
SubjectTerms | Adverse pregnancy outcomes Analysis Cesarean section Genetic disorders Gestational weight gain Pregnant women Type 2 diabetes Type 2 diabetes mellitus |
Title | Optimal gestational weight gain in women with pregestational type 2 diabetes: a population-based cohort study in China |
URI | https://www.ncbi.nlm.nih.gov/pubmed/40826373 https://www.proquest.com/docview/3240912339 https://pubmed.ncbi.nlm.nih.gov/PMC12359865 https://doaj.org/article/773812addbee4e1292c1cdcbc3f99bbd |
Volume | 17 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEB_0BPFF_LZ6rhEEH6Rcm7RN4tud3HkId4p4sG8hmaZ6D_aWvT3333cm3S5bfPBFKH1ohtJkZjIfzfwG4K1sfG3aiLlU2FCAQqrodWnzqlNSBy1jgZzQPztvTi-qz_N6vtPqi8-EDfDAw8IdaE02RZIWhhirSNZJYoktBlSdtSG0vPuSzRuDqWEPJi9YV2OJjGkOrmmn5lIyyQfVyCbm64kZSmj9f-_JO0ZpemByxwKdPID7G9dRHA6f_BBuxf4R3D3b_Bx_DL-_kPr_Igr-ZbTJ8Yl1Sn2KH_6yF3QlwAXByVexWMZdQs7FCinGXOwH4cVi29wrZ2PXCu6mu1yJBEnLb0vNt5_Axcnx94-n-aatQo7kG61zSwvXaVrBrvBdQEQVilA1gay9L4vWWF1XoVSxaDvkYkJttdJYF1hGaZDcr6ew11_18TkIXzA6vuabr6xGjx3pN0oKfKPShc_g_bjKbjGgZ7gUdZjGDTxxxBOXeOLWGRwxI7aUjHydHpA8uI08uH_JQwavmY1uKCPd6q87NBRylwz1k8G7RMEaTNykjx4KEWhKjIU1odyfUJLm4WT4zSgqjof4uFofr26uHaMcWvIJlM3g2SA621lxh-9GaZWBmQjVZNrTkf7yZwL-5rpma5r6xf9YqJdwTyaFMHlp9mFvtbyJr8jBWoUZ3NZzPYM7R8fnX7_NkmbR_dO8_ANw8SlU |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Optimal+gestational+weight+gain+in+women+with+pregestational+type+2+diabetes%3A+a+population-based+cohort+study+in+China&rft.jtitle=Diabetology+and+metabolic+syndrome&rft.au=Xue%2C+Yiwei&rft.au=Cui%2C+Zifeng&rft.au=Shu%2C+Xinyu&rft.au=Juan%2C+Juan&rft.date=2025-08-18&rft.pub=BioMed+Central+Ltd&rft.issn=1758-5996&rft.eissn=1758-5996&rft.volume=17&rft.issue=1&rft_id=info:doi/10.1186%2Fs13098-025-01782-w&rft.externalDocID=A852318370 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1758-5996&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1758-5996&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1758-5996&client=summon |